期刊文献+

塞来昔布对NB4细胞增殖、凋亡及VEGF表达的影响 被引量:3

Effects of Celecoxib on Proliferation,Apoptosis and VEGF Expression in NB4 Cells
下载PDF
导出
摘要 目的探讨塞来昔布对急性早幼粒细胞白血病细胞的抑制作用及可能机制。方法不同浓度塞来昔布处理急性早幼粒细胞白血病细胞株NB4,MTT法检测塞来昔布作用后细胞的增殖情况。采用流式细胞术测定NB4细胞周期分布及凋亡;Western blot检测细胞凋亡相关蛋白Bcl-2表达以及RT-PCR检测塞来昔布作用对VEGF、HIF-1α在mRNA水平的表达。结果 MTT显示塞来昔布对NB4细胞生长有明显抑制作用。20~80μmol/L塞来昔布作用24h,NB4细胞G0/G1期比例明显升高,而S期细胞比例下降(P<0.05);塞来昔布处理组细胞凋亡率明显高于对照组,Western blot显示Bcl-2蛋白表达下调(P<0.05);RT-PCR显示塞来昔布可抑制VEGF及HIF-1α的mRNA表达。结论塞来昔布在体外可抑制急性早幼粒细胞白血病细胞增殖并诱导凋亡。 Objective To explore effects of celecoxib on proliferation,apoptosis and VEGF expression in acute promyelocytic leukemia cell(NB4).Methods After acute promyelocytic leukemia cell line NB4 was treated by different concentrations of celecoxib,cell proliferation was detected by MTT assay.NB4 cell cycle distribution and apoptosis were measured by flow cytometry.Apoptosis related protein,the Bcl-2 expression and VEGF,HIF-1α mRNA levels were detected by Western blot and RT-PCR,respectively.Results The proliferation of NB4 cells was significantly inhibited by celecoxib.Celecoxib could increase the percentage of G0/G1 cells and decrease S phase cells.The rate of apoptosis cell was increased in NB4 cells with 20-80 μmol/L celecoxib treatment for 24h.Celecoxib significantly induced apoptosis,and down-regulated Bcl-2 protein(P0.05).VEGF and HIF-1α mRNA levels were inhibited in NB4 cells after celecoxib treatment.Conclusion Celecoxib could inhibit cell proliferation,arrest cycles and induce apoptosis,through down-regulation of VEGF and HIF-1α in acute promyelocytic leukemia cells in vitro.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2013年第2期147-150,共4页 Cancer Research on Prevention and Treatment
基金 河北省卫生厅医学科学研究重点课题资助项目(20090014)
关键词 急性早幼粒细胞白血病 塞来昔布 NB4细胞 细胞凋亡 细胞周期 Acute promyelocytic leukemia Celecoxib NB4 cells Apoptosis Cell cycle
  • 相关文献

参考文献18

  • 1Zha S,Yegnasubramanian V,Nelson WG. Cyclooxygenases in cancer:progress and perspective[J].Cancer Letters,2004,(01):1-20. 被引量:1
  • 2Bernard MP,Bancos S,Sime PJ. Targeting cyclooxygen ase-2 in hematological malignancies:rationale and promise[J].Current Pharmaceutical Design,2008,(21):2051-2060. 被引量:1
  • 3Hasegawa K,Ohashi Y,Ishikawa K. Expression of cyclooxygenase-2 in uterine endometrial cancer and anti-tumor effects of a selective COX-2 inhibitor[J].International Journal of Oncology,2005,(05):1419-1428. 被引量:1
  • 4Arunasree KM,Roy KR,Anilkumar K. Imatinib-resistant K562 cells are more sensitive to celecoxib,a selective COX-2 inhibitor:Role of COX-2 and MDR-1[J].Leukemia Research,2008,(06):855-864.doi:10.1016/j.leukres.2007.11.007. 被引量:1
  • 5Sobolewski C,Cerella C,Dicato M. The role of cyclooxy genase-2 in cell proliferation and cell death in human malignancies[J].Int J Cell Biol,2010.215158. 被引量:1
  • 6Ding X,Zhu C,Qiang H. Enhancing antitumor effects in pancreatic cancer cells by combined use of COX 2 and 5 LOX inhibitors[J].Biomedicine and Pharmacotherapy,2011,(07):486-490. 被引量:1
  • 7Sminia P,Kuipers G,Geldof A. COX 2 inhibitors act as radiosensitizer in tumor treatment[J].Biomedicine and Pharmacotherapy,2005,(Supple 2):S272-S275. 被引量:1
  • 8Zhang GS,Liu DS,Dai CW. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest,caspase-3 activation,and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib[J].American Journal of Hematology,2006,(04):242-255.doi:10.1002/ajh.20542. 被引量:1
  • 9Dor Y,Porat R,Keshet E. Vascular endothelial growth factor and vascular adjustments to perturbations in oxygen homeostasis[J].American Journal of Physiology-Cell Physiology,2001,(06):1367-1374. 被引量:1
  • 10Kaelin WG Jr. The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma[J].Clinical Cancer Research,2007,(2 Pt 2):680s-684s.doi:10.1158/1078-0432.CCR-06-1865. 被引量:1

二级参考文献34

  • 1许文林,沈慧玲,袁伟,江云伟,吴朝阳,费霞,唐华容.K562细胞血管内皮生长因子自分泌链作用的实验研究[J].中华血液学杂志,2007,28(3):189-193. 被引量:6
  • 2Otrock ZK, Hatoum HA, Awada AH, et al. Hypoxia-inducible factor in cancer angiogenesis: structure, regulation and clinical perspectives. Crit Rev Oncol Hematol,2009;70(2) :93 -102. 被引量:1
  • 3Das B, Yeger H, Tsuchida R, et al. A hypoxia-driven vascular endothelial growth factor/Fltl autocrine loop interacts with hypoxia- inducible factor-1 alpha through mitogen-activated protein kinase/ extracellular signal-regulated kinase 1/2 pathway in neuroblastoma. Cancer Res ,2005 ;65 ( 16 ) :7267 - 7275. 被引量:1
  • 4Podar K, Anderson KC. The pathophysiologic role of VEGF in hematologic malignancies : therapeutic implications. Blood, 2005 ; 105(4) :1383 - 1395. 被引量:1
  • 5Yeo EJ, Chun YS, Park JW. New anticancer strategies targeting HIF-1. Biochem Pharmacol,2004 ;68 (6) : 1061 - 1069. 被引量:1
  • 6Chung JG, Yang JS, Huang LJ, et al. Proteomic approach to studying the cytotoxicity of YC-I on U937 leukemia ceils and antileukemia activity in orthotopic model of leukemia mice. Proteomics ,2007 ;7 ( 18 ) : 3305 - 3317. 被引量:1
  • 7Clerici C, Planes C. Gene regulation in the adaptive process to hypoxia in lung epithelial ceils, Am J Physiol Lung Cell Mol Physiol,2009 ;296 ( 3 ) : 267 - 274. 被引量:1
  • 8Li WW, Hutnik M, Gehr G. Antiangiogenesis in haematological malignancies. Br J Haematol,2008 ; 143 (5) :622 - 631. 被引量:1
  • 9Wellmann S, Guschmann M, Griethe W, et al. Activation of the HIF pathway in childhood ALL, prognostic implications of VEGF. Leukemia,2004 ; 18 ( 5 ) :926 - 933. 被引量:1
  • 10Lu L, Zhang L, Xiao Z, et al. Neuropilin-1 in acute myeloid leukemia: expression and role in proliferation and migration of leukemia cells. Leuk Lymphoma,2008 ;49(2) :331 -338. 被引量:1

共引文献5

同被引文献27

  • 1牛国梁,王辉,谢荣俊,张树友.塞来昔布对乳腺癌细胞株的放射增敏作用[J].中国癌症杂志,2011,21(4):272-276. 被引量:4
  • 2OHSAWA M, IKURA Y, FUKUSHIMA H, et al. Immunohisto- chemical expression of multidrug resistance proteins as a predictor of poor response to chemotherapy and prognosis in patients with nodal diffuse large B-cell lymphoma [ J ]. Oncology, 2005,68 (4/ 6 ) : 422-431. DOI : 10.1016/0009-2509 ( 94 ) 00216-E. 被引量:1
  • 3MA M, ZHAO L M, SUN G G, et al. Mda-7/IL-24 enhances sensitivity of B cell lymphoma to chemotherapy drugs [ J]. Oncol Rep, 2016, 35 (5): 3122-3130. DOI: 10. 3892/or. 2016. 4622. 被引量:1
  • 4CREA F, DUHAGON SERRAT M A, HURT E M, et al. BMI1 silencing enhances docetaxel activity and impairs antioxidant re- sponse in prostate cancer [ J ]. Int J Cancer, 2011, 128 ( 8 ) : 1946-1954. DOI: 10. 1002/ijc. 25522. 被引量:1
  • 5TOKINIWA H. Topoisomerase I1 alpha expression and the Ki457 labeling index correlate with prognostic factors in estrogen receptor- positive and human epidermal growth factor type-2-negative breast cancer [J]. Breast Cancer, 2011, 19(4) : 309-314. DOI: 10. 1007/s12282-011 - 0291-4. 被引量:1
  • 6LU D, SHI H C, WANG Z X, et al. Multidrug resistance associat- ed biornarkers PGP, GST-pi, Topo-]I and LRP as prognostic fac- tors in primary ovarian carcinoma [ J]. Br J Biomed Sci, 2011,68 (2) : 69-74. DOI: 10. 1097/00005392-199608000<)0072. 被引量:1
  • 7ZHU W Y, HUNAG Y Y, LIU X G, et al. Prognostic evaluation of CapG, Gelsolin, P-gp, GSTP1, and Topo- I] proteins in non-small eell lung cancer [J]. Anat Rec, 2012, 295(2) : 208-214. DOI: 10. 1002/at. 21523. 被引量:1
  • 8ZHU D, WAN X, HUANG H, et al. Knockdown of Bmil inhibits the sternness properties and tumorigenicity of human bladder cancer stem cell-like side population cells [J]. Oncol Rep, 2014, 31 (2) : 727-736. DOI:10. 3892/or. 2013. 2919. 被引量:1
  • 9王轶楠,李红民,马守东,赵郁,刘卫东,岳海书.P-gp170、GST-π、TOPOⅡ在外周T细胞淋巴瘤中的表达及意义[J].现代肿瘤医学,2009,17(8):1543-1546. 被引量:4
  • 10赵连梅,韩丽娜,商晓辉,单保恩.木鳖子醇提物对黑素瘤B16细胞增殖的抑制及其可能机制[J].中国肿瘤生物治疗杂志,2010,17(1):13-18. 被引量:9

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部